PLB-015
/ Primelink Bio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 18, 2026
PLB-015 a novel anti-HER2 dual payload ADC for the treatment of HER2 positive solid tumors
(AACR 2026)
- "Abstract is embargoed at this time."
ADC • Late-breaking abstract • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1